Cargando…
Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial
INTRODUCTION: HIV infection and certain antiretroviral therapy (ART) medications increase atherosclerotic cardiovascular disease risk, mediated, in part, through traditional cardiovascular disease risk factors. METHODS AND RESULTS: We studied cardiovascular disease risk factor changes in the START (...
Autores principales: | Baker, Jason V., Sharma, Shweta, Achhra, Amit C., Bernardino, Jose Ignacio, Bogner, Johannes R., Duprez, Daniel, Emery, Sean, Gazzard, Brian, Gordin, Jonathan, Grandits, Greg, Phillips, Andrew N., Schwarze, Siegfried, Soliman, Elsayed Z., Spector, Stephen A., Tambussi, Giuseppe, Lundgren, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524070/ https://www.ncbi.nlm.nih.gov/pubmed/28533305 http://dx.doi.org/10.1161/JAHA.116.004987 |
Ejemplares similares
-
Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial
por: Dharan, Nila J., et al.
Publicado: (2019) -
A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection
por: Ananworanich, Jintanat, et al.
Publicado: (2008) -
Immediate start of antiretroviral, why not?
por: Matsuda, Elaine Monteiro, et al.
Publicado: (2018) -
Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
por: Paci, Paola, et al.
Publicado: (2009) -
Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial
por: Baker, Jason V., et al.
Publicado: (2016)